123 related articles for article (PubMed ID: 1347417)
1. Correlations between c-erb beta-2 oncogene amplification and the expression of its mRNA and protein in human breast carcinomas.
Bandyopadhyay D; Dani HD; Samant UC; Redkar AA; Mittra I
Oncology; 1992; 49(1):9-14. PubMed ID: 1347417
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancers.
Delvenne CG; Winkler-Gol RA; Piccart MJ; Hustin J; Michaux D; Leclercq G; Nogaret JM; Autier P
Eur J Cancer; 1992; 28(2-3):700-5. PubMed ID: 1350458
[TBL] [Abstract][Full Text] [Related]
5. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
Heintz NH; Leslie KO; Rogers LA; Howard PL
Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
[TBL] [Abstract][Full Text] [Related]
6. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
7. C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.
Parkes HC; Lillycrop K; Howell A; Craig RK
Br J Cancer; 1990 Jan; 61(1):39-45. PubMed ID: 2153396
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP
Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168
[TBL] [Abstract][Full Text] [Related]
9. Alterations in copy number of c-erbB-2 and c-myc proto-oncogenes in advanced stage of human breast cancer.
Tsuda H; Hirohashi S; Hirota T; Shimosato Y
Acta Pathol Jpn; 1991 Jan; 41(1):19-23. PubMed ID: 1674395
[TBL] [Abstract][Full Text] [Related]
10. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
Jungehülsing M; Volling P
HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
Nagai MA; Marques LA; Torloni H; Brentani MM
Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
[TBL] [Abstract][Full Text] [Related]
12. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
13. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner MM; Zeillinger R; Theillet C
Br J Cancer; 1996 Dec; 74(12):1984-9. PubMed ID: 8980401
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
Tervahauta A; Eskelinen M; Syrjänen S; Lipponen P; Pajarinen P; Syrjänen K
Anticancer Res; 1991; 11(5):1677-81. PubMed ID: 1685075
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
16. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
Zhang X; Silva E; Gershenson D; Hung MC
Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry.
Kerns BJ; Pence JC; Huper G; Kinney RB; Iglehart JD
J Histochem Cytochem; 1990 Dec; 38(12):1823-30. PubMed ID: 1979342
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p185 is not related to erbB2 amplification in ovarian cancer.
Morali F; Cattabeni M; Tagliabue E; Campiglio M; Menard S; Marzola M; Lucchini V; Colombo N; Mangioni C; Redaelli L
Ann Oncol; 1993 Nov; 4(9):775-9. PubMed ID: 7904177
[TBL] [Abstract][Full Text] [Related]
19. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.
Zhau HE; Zhang X; von Eschenbach AC; Scorsone K; Babaian RJ; Ro JY; Hung MC
Mol Carcinog; 1990; 3(5):254-7. PubMed ID: 1978777
[TBL] [Abstract][Full Text] [Related]
20. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]